Neuss Michael N, Polovich Martha, McNiff Kristen, Esper Peg, Gilmore Terry R, LeFebvre Kristine B, Schulmeister Lisa, Jacobson Joseph O
Vanderbilt Ingram Cancer Center, Nashville TN, USA.
Oncol Nurs Forum. 2013 May 1;40(3):225-33. doi: 10.1188/13.ONF.40-03AP2.
In 2009, the American Society of Clinical Oncology (ASCO) and the Oncology Nursing Society (ONS) published standards for the safe use of parenteral chemotherapy in the outpatient setting, including issues of practitioner orders, preparation, and administration of medication. In 2011, these were updated to include inpatient facilities. In December 2011, a multistakeholder workgroup met to address the issues associated with orally administered antineoplastics, under the leadership of ASCO and ONS. The workgroup participants developed recommended standards, which were presented for public comment. Public comments informed final edits, and the final standards were reviewed and approved by the ASCO and ONS Boards of Directors. Significant newly identified recommendations include those associated with drug prescription and the necessity of ascertaining that prescriptions are filled. In addition, the importance of patient and family education regarding administration schedules, exception procedures, disposal of unused oral medication, and aspects of continuity of care across settings were identified. This article presents the newly developed standards.
2009年，美国临床肿瘤学会（ASCO）和肿瘤护理学会（ONS）发布了门诊环境中肠外化疗安全使用标准，包括执业医师医嘱、药物准备和给药等问题。2011年，这些标准进行了更新，将住院设施纳入其中。2011年12月，一个多利益相关方工作组在ASCO和ONS的领导下召开会议，以解决与口服抗肿瘤药相关的问题。工作组参与者制定了推荐标准，并征求公众意见。公众意见为最终编辑提供了参考，最终标准经ASCO和ONS董事会审查并批准。新确定的重要建议包括与药物处方相关的建议以及确保处方得到配药的必要性。此外，还确定了对患者及其家属进行给药时间表、例外程序、未使用口服药物处置以及不同环境下护理连续性方面教育的重要性。本文介绍了新制定的标准。
